ISB 2001
Showing 1 - 25 of 479
Relapsed/Refractory Multiple Myeloma Trial in Benowa (ISB 2001)
Not yet recruiting
- Relapsed/Refractory Multiple Myeloma
- ISB 2001
-
Benowa, Queensland, AustraliaPindara Private Hospital
May 18, 2023
Total Shoulder Arthroplasty Trial in Minneapolis (bupivacaine., Saline)
Not yet recruiting
- Total Shoulder Arthroplasty
-
Minneapolis, MinnesotaUniversity of Minnesota
Nov 15, 2023
Shoulder Surgeries Operations Trial in Zagazig (diaghragm affection by ultrasound before and after the blocks)
Recruiting
- Shoulder Surgeries Operations
- diaghragm affection by ultrasound before and after the blocks
-
Zagazig, Sharqia, EgyptEmad Hamdy Mohamed Morsy
Jun 16, 2023
Pain, Postoperative, Shoulder Pain, Surgical Procedure, Unspecified Trial in Santiago (Interscalene Block, Infraclavicular -
Not yet recruiting
- Pain, Postoperative
- +3 more
- Interscalene Block
- Infraclavicular - Anterior Supraescapular Nerve Blocks
-
Santiago, Metropolitana, ChileHospital Clínico Universidad de Chile
Nov 14, 2022
Pericapsular Nerve Block, Interscalene Nerve Block, Shoulder Arthroscopy Trial in Kafrelsheikh (The pericapsular nerve group,
Not yet recruiting
- Pericapsular Nerve Block
- +2 more
- The pericapsular nerve group
- Interscalene brachial plexus block
-
Kafrelsheikh, EgyptMohammed Fouad Mohamed Algyar
Mar 25, 2023
Interscalene Block, Erector Spinae Plane Block, Arthroscopy Trial in Tanta (Erector spinae plane block, Interscalene brachial
Not yet recruiting
- Interscalene Block
- +2 more
- Erector spinae plane block
- Interscalene brachial plexus block
-
Tanta, El-Gharbia, EgyptIslam Morsy
Dec 4, 2022
Moderate to Severe Atopic Dermatitis Trial in Worldwide (ISB 830 - Part 1 Group 1, ISB 830 - Part 1 Group 2, ISB 830 - Part 1
Completed
- Moderate to Severe Atopic Dermatitis
- ISB 830 - Part 1 Group 1
- +5 more
-
Birmingham, Alabama
- +82 more
Jul 26, 2022
Shoulder Fractures Trial in Hong Kong (Liposomal bupivacaine, Standard bupivacaine)
Recruiting
- Shoulder Fractures
- Liposomal bupivacaine
- Standard bupivacaine
-
Hong Kong, Hong Kong
- +1 more
Jul 21, 2022
Shoulder Arthroplasty Trial in Winston-Salem (Liposomal bupivacaine, Bupivacaine with adjuvants)
Enrolling by invitation
- Shoulder Arthroplasty
- Liposomal bupivacaine
- Bupivacaine with adjuvants
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Feb 14, 2022
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy Trial (NTLA-2001, Placebo)
Not yet recruiting
- Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
- NTLA-2001
- Placebo
- (no location specified)
Nov 8, 2023
Relapsed/Refractory Multiple Myeloma Trial in Australia, United States (ISB 1442 SC injection escalating doses, ISB 1442 SC
Not yet recruiting
- Relapsed/Refractory Multiple Myeloma
- ISB 1442 SC injection escalating doses
- ISB 1442 SC injection at RP2D
-
New York, New York
- +5 more
Jun 17, 2022
Relapsed/Refractory Multiple Myeloma Trial in France, United States (ISB 1342)
Recruiting
- Relapsed/Refractory Multiple Myeloma
- ISB 1342
-
Little Rock, Arkansas
- +21 more
May 10, 2022
Joint Disease, Pain, Pain, Acute Trial in New York (Bupivacaine, Ultrasound)
Completed
- Joint Disease
- +3 more
- Bupivacaine
- Ultrasound
-
New York, New YorkHospital for Special Surgery
Apr 19, 2022
Postoperative Pain Trial in Madinat al Fayyum (ICSSB group, ISB group)
Completed
- Postoperative Pain
- ICSSB group
- ISB group
-
Madīnat al Fayyūm, Faiyum Governorate, EgyptFayoum University hospital
Mar 15, 2022
Shoulder Pain Trial in New York (Exparel 133 MG Per 10 ML Injection, Dexamethasone)
Completed
- Shoulder Pain
- Exparel 133 MG Per 10 ML Injection
- Dexamethasone
-
New York, New YorkHospital for Special Surgery
Jul 7, 2022
Interscalene Nerve Block, Anterior Suprascapular Nerve Block, Arthroscopic Shoulder Surgery Trial in Tanta (interscalene nerve
Not yet recruiting
- Interscalene Nerve Block
- +2 more
- interscalene nerve block
- +2 more
-
Tanta, EL-Gharbia, EgyptShrouk Mohamed Elsawaf
Feb 13, 2023
Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small
Recruiting
- Relapsed or Refractory CD19+ B-cell Lymphoma
- +2 more
- TBI-2001
- +2 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jul 26, 2023
Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
Not yet recruiting
- Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
- +2 more
-
Auckland, New Zealand
- +2 more
Jan 24, 2023
Shoulder Pain Trial in New York (Liposomal Bupivacaine, 0.5% Bupivacaine HCL)
Completed
- Shoulder Pain
- Liposomal Bupivacaine
- 0.5% Bupivacaine HCL
-
New York, New YorkNYU Langone Health
Jan 3, 2022
Intensive Lifestyle Intervention on Employment, Earnings, and
Active, not recruiting
- Diabetes Mellitus, Type 2
- Intensive lifestyle intervention (ILI)
- Diabetes support and education (DSE)
- (no location specified)
Sep 29, 2022
Severe Hypertriglyceridemia Trial in Worldwide (ARO-APOC3, Placebo)
Active, not recruiting
- Severe Hypertriglyceridemia
- ARO-APOC3
- Placebo
-
Beverly Hills, California
- +72 more
Nov 29, 2022
Tuberous Sclerosis Complex Trial in United States (Ganaxolone)
Enrolling by invitation
- Tuberous Sclerosis Complex
-
Phoenix, Arizona
- +13 more
Jan 24, 2023
Hemi-diaphragm Dysfunction After Upper Extremity Nerve Blocks
Terminated
- Diaphragm Elevated
- Paresis
- Thorasys Tremoflo C-100 Airwave Oscillometry System (FOT)
-
Halifax, Nova Scotia, CanadaNSHA NHI site
Apr 13, 2021